US › Healthcare

Forian Inc (FORA)

US · Healthcare · Health Information Services

$2.52-6.32%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$6.9M
Revenue YoY
-2.9%
Net profit
$-3.4M
Profit YoY
-198.6%
EPS
$-0.06
EPS estimate
$0.01
Net margin
-49.1%

EPS came in at -0.06 against a street estimate of 0.01 — a miss of 731.2%.

Key statistics

Market cap
$67.8M
Forward P/E
24.1
P/B
2.28
Book value
$0.96
EPS (TTM)
$-0.09
52-week high
$2.94
52-week low
$1.64
50-day MA
$2.12
200-day MA
$2.13
Beta
0.93

Analyst view

Analysts rate Forian Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $2.10.

Shareholding

Insiders
51.75%
Institutions
14.90%

Largest institutional holders

FundStake
Staley Capital Advisers Inc3.52%
Vanguard Capital Management, LLC2.09%
Geode Capital Management, LLC0.62%
Vanguard Fiduciary Trust Co0.26%
OpenArc Corporate Advisory, LLC0.26%
BlackRock Inc0.22%
State Street Corp0.17%
Aufman Associates Inc0.17%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Forian Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.